相似文献
1
Susceptibility pattern and molecular type of species-specific Candida in oropharyngeal lesions of Indian human immunodeficiency virus-positive patients.
J Clin Microbiol. 2004 Mar;42(3):1260-2. doi: 10.1128/JCM.42.3.1260-1262.2004.
2
Replacement of Candida albicans with C. dubliniensis in human immunodeficiency virus-infected patients with oropharyngeal candidiasis treated with fluconazole.
J Clin Microbiol. 2002 Sep;40(9):3135-9. doi: 10.1128/JCM.40.9.3135-3139.2002.
3
Significance of isolation and drug susceptibility testing of non-Candida albicans species causing oropharyngeal candidiasis in HIV patients.
Southeast Asian J Trop Med Public Health. 2008 May;39(3):492-5.
4
Isolation, characterization and antifungal susceptibility pattern of Candida species causing oropharyngeal candidiasis in HIV positive patients.
J Commun Dis. 2008 Sep;40(3):177-81.
5
Colonization of human immunodeficiency virus-infected outpatients in Taiwan with Candida species.
J Clin Microbiol. 2005 Apr;43(4):1600-3. doi: 10.1128/JCM.43.4.1600-1603.2005.
6
Relationship between fluconazole sensitivity of Candida albicans isolates from HIV positive patients and serotype, adherence and CD4+ lymphocyte count.
Eur J Clin Microbiol Infect Dis. 1994 Sep;13(9):711-6. doi: 10.1007/BF02276053.
7
Detection of Candida dubliniensis in oropharyngeal samples from human immunodeficiency virus-infected patients in North America by primary CHROMagar candida screening and susceptibility testing of isolates.
J Clin Microbiol. 1998 Oct;36(10):3007-12. doi: 10.1128/JCM.36.10.3007-3012.1998.
8
Molecular epidemiology of Candida albicans strains isolated from the oropharynx of HIV-positive patients at successive clinic visits.
Med Mycol. 2001 Aug;39(4):341-52. doi: 10.1080/mmy.39.4.341.352.
9
Pseudomembranous candidiasis in HIV/AIDS patients in Cali, Colombia.
Mycopathologia. 2013 Feb;175(1-2):91-8. doi: 10.1007/s11046-012-9593-0. Epub 2012 Oct 21.
10
Oral Candida isolates among HIV-infected subjects in Nigeria.
J Microbiol Immunol Infect. 2011 Jun;44(3):172-7. doi: 10.1016/j.jmii.2011.01.028. Epub 2011 Jan 20.
引用本文的文献
1
Epidemiology and Prevalence of Oral Candidiasis in HIV Patients From Chad in the Post-HAART Era.
Front Microbiol. 2022 Feb 17;13:844069. doi: 10.3389/fmicb.2022.844069. eCollection 2022.
2
Association of oral candidal species with human immunodeficiency virus patients of West Godavari district, Andhra Pradesh - An study.
J Oral Maxillofac Pathol. 2021 Jan-Apr;25(1):147-153. doi: 10.4103/jomfp.jomfp_504_20. Epub 2021 May 14.
3
Oral candidiasis in HIV-uninfected pediatric population in areas with limited fungal diagnosis: A case study from a tertiary hospital, Tanzania.
Ther Adv Infect Dis. 2021 May 20;8:20499361211016964. doi: 10.1177/20499361211016964. eCollection 2021 Jan-Dec.
4
Antifungal Resistance of Species Isolated from HIV Patients in a Tertiary Care Hospital, Mysuru, Karnataka.
Indian J Dermatol. 2020 Sep-Oct;65(5):423-425. doi: 10.4103/ijd.IJD_385_19.
5
Biofilm-Producing Species Causing Oropharyngeal Candidiasis in HIV Patients Attending Sukraraj Tropical and Infectious Diseases Hospital in Kathmandu, Nepal.
HIV AIDS (Auckl). 2020 Jun 15;12:211-220. doi: 10.2147/HIV.S255698. eCollection 2020.
6
Clinico-mycological analysis and antifungal resistance pattern in human immunodeficiency virus-associated candidiasis: An Indian perspective.
Indian J Sex Transm Dis AIDS. 2018 Jul-Dec;39(2):111-119. doi: 10.4103/ijstd.IJSTD_89_17.
7
Oral Candidiasis among Cancer Patients Attending a Tertiary Care Hospital in Chennai, South India: An Evaluation of Clinicomycological Association and Antifungal Susceptibility Pattern.
Can J Infect Dis Med Microbiol. 2016;2016:8758461. doi: 10.1155/2016/8758461. Epub 2016 Jun 14.
8
Candida Species Prevalence Profile in HIV Seropositive Patients from a Major Tertiary Care Hospital in New Delhi, India.
J Pathog. 2016;2016:6204804. doi: 10.1155/2016/6204804. Epub 2016 Mar 22.
9
Diversity and antifungal resistance patterns of prevalent opportunistic pathogenic yeasts colonizing the oral cavities of asymptomatic human immunodeficiency virus-infected individuals, and their relation to CD4(+) counts.
Indian J Sex Transm Dis AIDS. 2015 Jan-Jun;36(1):53-8. doi: 10.4103/0253-7184.156724.
10
Sub-inhibitory concentrations of antifungals suppress hemolysin activity of oral Candida albicans and Candida tropicalis isolates from HIV-infected individuals.
Mycopathologia. 2014 Oct;178(3-4):207-15. doi: 10.1007/s11046-014-9802-0. Epub 2014 Aug 21.
本文引用的文献
1
Persistence of oropharyngeal Candida albicans strains with reduced susceptibilities to fluconazole among human immunodeficiency virus-seropositive children and adults in a long-term care facility.
J Clin Microbiol. 2003 May;41(5):1833-7. doi: 10.1128/JCM.41.5.1833-1837.2003.
2
Invasive oesophageal candidiasis: current and developing treatment options.
Drugs. 2003;63(10):971-89. doi: 10.2165/00003495-200363100-00004.
3
Immunohistochemical evaluation of T cells in oral lesions from human immunodeficiency virus-positive persons with oropharyngeal candidiasis.
Infect Immun. 2003 Feb;71(2):956-63. doi: 10.1128/IAI.71.2.956-963.2003.
4
Distinct protective host defenses against oral and vaginal candidiasis.
Med Mycol. 2002 Aug;40(4):359-75.
5
Replacement of Candida albicans with C. dubliniensis in human immunodeficiency virus-infected patients with oropharyngeal candidiasis treated with fluconazole.
J Clin Microbiol. 2002 Sep;40(9):3135-9. doi: 10.1128/JCM.40.9.3135-3139.2002.
6
Immunity to Candida.
Oral Dis. 2002;8 Suppl 2:69-75. doi: 10.1034/j.1601-0825.2002.00015.x.
7
Transcription initiation of genes associated with azole resistance in Candida albicans.
Med Mycol. 2002 Feb;40(1):73-81. doi: 10.1080/mmy.40.1.73.81.
8
Carriage frequency, intensity of carriage, and strains of oral yeast species vary in the progression to oral candidiasis in human immunodeficiency virus-positive individuals.
J Clin Microbiol. 2002 Feb;40(2):341-50. doi: 10.1128/JCM.40.2.341-350.2002.
9
Recovery of Candida dubliniensis and other yeasts from human immunodeficiency virus-associated periodontal lesions.
J Clin Microbiol. 2001 Dec;39(12):4520-2. doi: 10.1128/JCM.39.12.4520-4522.2001.
10
Therapeutic options for the management of oropharyngeal and esophageal candidiasis in HIV/AIDS patients.
HIV Clin Trials. 2000 Jul-Aug;1(1):47-59. doi: 10.1310/T7A7-1E63-2KA0-JKWD.
Zotero 插件